Data
- - - Truveta Data
      
      A complete, living view of patient care
    - Explore Truveta Data
  - - Capabilities
      
      Representative, complete, and real-time
  - - Therapeutic areas
      
      Explore every disease with longitudinal, clinical context
    - - Cardiovascular
      - Oncology
  - - Evidence
      
      Build trust through rigorous analytics and expertise
    - - Trusted research environment
      - Evidence Services
Intelligence
- - - Truveta Intelligence
      
      Answers in minutes, not months
    - Explore Truveta Intelligence
  - - Capabilities
      
      Ask what matters now
    - - Ask
  - - Evidence
      
      Verify the methodology behind the results
    - - Verify
Customers
- - - Truveta customers
      
      Trusted by leading life science, public health, and healthcare organizations
  - - Who we serve
Research
About
- - - Saving Lives with Data
      
      Built with and owned by US health systems to improve patient care
Contact us
Sign in



Close

Research

Featured research

early uptake of GLP-1 Foundayo pill for obesity

Early uptake of oral orforglipron (Foundayo pill) for obesity following FDA approval

More than 2 in 5 patients (40.3%) initiating oral orforglipron (Foundayo pill) had no prior evidence of GLP-1-based medication use, suggesting early uptake extends beyond patients already receiving injectable therapies. Among patients with prior GLP-1-based medication...

Research graphic highlighting increased measles immunity testing during periods of measles outbreak activity.

Measles outbreaks linked to increases in immunity testing among adults over 50

Truveta Research found measles titer testing among adults over 50 increased during the 2019 and 2025 outbreaks, with a sharp rise in Texas in 2025.

Truveta graphic promoting research on e-bike and e-scooter injuries, featuring the headline "E-bike and e-scooter injuries rising rapidly" with a subtitle highlighting increasing emergency department visits among children and adolescents over a background line chart of injury trends.

Emergency department visits related to e-bike and e-scooter injuries are rising rapidly among children and adolescents

Truveta Research finds e-bike and e-scooter injury ED visits rose 7.5-fold among children, with head and neck injuries most common.

Truveta graphic highlighting a JMCP study of real-world switching from Humira (adalimumab) to biosimilars in the United States, with a line chart showing increased biosimilar adoption after formulary changes.

Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar

A real-world study found 16% of patients switched back to Humira after starting an adalimumab biosimilar, highlighting transition challenges.

Research graphic highlighting rising progesterone-containing hormone replacement therapy use among women from 2018 to 2026.

Progesterone-containing hormone replacement therapy use is rising

Progesterone-containing hormone replacement therapy use is rising. Truveta Research found prescribing increased more than fourfold between 2018 and 2026.

Featured research topics

GLP-1

Oncology

Flu/RSV

Measles

Cardiovascular